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Cerebral small vessel diseaseThere is evidence that subtle breakdown of the blood–brain barrier (BBB) is a pathophysiological component of
several diseases, including cerebral small vessel disease and some dementias. Dynamic contrast-enhanced MRI
(DCE-MRI) combined with tracer kinetic modelling is widely used for assessing permeability and perfusion in
brain tumours and body tissues where contrast agents readily accumulate in the extracellular space. However,
in diseases where leakage is subtle, the optimal approach for measuring BBB integrity is likely to differ since
the magnitude and rate of enhancement caused by leakage are extremely low; several methods have been
reported in the literature, yielding a wide range of parameters even in healthy subjects. We hypothesised that
the Patlak model is a suitable approach for measuring low-level BBB permeability with low temporal resolution
and high spatial resolution and brain coverage, and that normal levels of scanner instability would inﬂuence
permeability measurements. DCE-MRI was performed in a cohort of mild stroke patients (n = 201) with a
range of cerebral small vessel disease severity. We ﬁtted these data to a set of nested tracer kinetic models,
ranking their performance according to the Akaike information criterion. To assess the inﬂuence of scanner drift,
we scanned 15 healthy volunteers that underwent a “sham”DCE-MRI procedurewithout administration of contrast
agent. Numerical simulationswere performed to investigatemodel validity and the effect of scanner drift. The Patlak
modelwas found to bemost appropriate forﬁtting low-permeability data, and the simulations showed vp andKTrans
estimates to be reasonably robust to themodel assumptions. However, signal drift (measured at approximately 0.1%
perminute and comparable to literature reports in other settings) led to systematic errors in calculated tracer kinetic
parameters, particularly at low permeabilities. Our ﬁndings justify the growing use of the Patlak model in low-per-
meability states, which has the potential to provide valuable information regarding BBB integrity in a range of dis-
eases. However, absolute values of the resulting tracer kinetic parameters should be interpreted with extreme
caution, and the size and inﬂuence of signal drift should be measured where possible.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Imaging and biochemical investigations suggest that breakdown of
the blood–brain barrier (BBB) may be implicated in ageing and the
pathophysiology of several diseases, including cerebral small vessel
disease, lacunar stroke, vascular dementia and Alzheimer's disease
(Farrall and Wardlaw, 2009; Iadecola, 2013; Wardlaw et al., 2013a).
Reliable in vivo methods for measuring microvascular integrity areentre, Neuroimaging Sciences,
we Road, Edinburgh EH4 2XU,
.j.thrippleton@ed.ac.uk
age),
hen.Makin@ed.ac.uk
@ed.ac.uk (E. Sakka),
. This is an open access article undertherefore essential to investigate the mechanisms underlying such
diseases and to assess potential therapies. The cerebrospinal ﬂuid
(CSF) to plasma albumin ratio is a widely accepted in vivo marker of
BBB integrity but is non-speciﬁc and highly invasive.
The most widely used imaging method for assessing BBB integrity
and other microvascular properties is dynamic contrast-enhanced MRI
(DCE-MRI), in which a paramagnetic contrast agent is injected and the
time dependence of the resulting T1-weighted image enhancement
measured. There are many approaches to analysing such data, from
simple heuristic measures to a growing library of tracer kinetic models
(Sourbron and Buckley, 2012), which aim to estimate physiological
parameters including blood ﬂow, blood volume and the rate of extra-
vascular leakage. These techniques have been developed and applied
primarily in neurooncology and body imaging, where contrast uptake
in tissue is typically large and rapid. However, the optimal modelling
approach for research in diseases where the BBB remains largely intactthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Representative MRI data and tissue segmentation. FLAIR image (left) and tissue
masks superimposedon FLAIR image (CSF: cerebrospinalﬂuid, NAWM:normal-appearing
white matter, WMH: white matter hyperintensities, DGM: deep grey matter, RSL: recent
stroke lesion).
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groups have applied semi-quantitative approaches, comparing signal
enhancement–time curves between patient groups to avoid assump-
tions inherent in modelling (Wardlaw et al., 2008) or calculating
heuristic quantities such as “area under curve” (Topakian et al., 2010).
These approaches have the advantage of being straightforward to
implement and do not require advanced image processing, but they
do not distinguish between intra- and extravascular contrast and may
be inﬂuenced by the acquisition parameters and other variables.
Recently, a number of more complex, model-based approaches to
quantifying subtle BBB leakage have been suggested, with applications
in cognitive impairment (Montagne et al., 2015; Taheri et al., 2011a),
healthy subjects (Cramer and Larsson, 2014), and in the normal-
appearing tissue of patients with multiple sclerosis (Cramer et al.,
2014), primary brain tumours (Larsson et al., 2009; Sourbron et al.,
2009) and acute stroke (Thornhill et al., 2010), involving a range of
acquisition and analysis methods.
In this work, we performed DCE-MRI in a large cohort of mild stroke
patients with a range of small vessel disease features and severity. We
aimed to determine the tracer kineticmodelling approachmost suitable
for assessing subtle BBB leakage using a data-driven approach, to deter-
mine its validity both in theory and experimentally and to obtain tracer
kinetic parameters for normal-appearing tissues and lesions. We
hypothesised that low temporal resolution data analysed using the
Patlak model is appropriate for measuring low-level BBB permeability
with high spatial resolution and brain coverage, and that scanner insta-
bility causes signiﬁcant systematic errors in quantitative permeability
measurements.
Materials and methods
Clinical cohort
Patients
We recruited 264 patients with ﬁrst clinically evident mild
(i.e., expected to be non-disabling) ischaemic stroke from the local
stroke service. Included patients had to be over 18 years old, have a
deﬁnite diagnosis of ischaemic stroke, be able to consent themselves,
have anMRI scan at diagnosis and bemedically stable enough to return
for a DCE-MRI scan at between 1 and 3 months post-stroke and a
follow-up at 1 year. All patients underwent clinical assessment by a
stroke physician, diagnostic MR imaging and cognitive testing at pre-
sentation. An expert panel of stroke physicians and neuro-radiologists
assessed each case in order to conﬁrm the diagnosis of ischaemic stroke
and classify the ischaemic stroke subtype. DCE-MRI was performed a
minimum of 1 month after the stroke in order to avoid acute effects of
the stroke on the local BBB. This study was approved by the Lothian
Ethics of Medical Research Committee (REC 09/81101/54) and the
NHS Lothian R + D Ofﬁce (2009/W/NEU/14), and all patients gave
written informed consent.
MRI
All imaging was performed on a 1.5 T MRI scanner (Signa HDxt,
General Electric, Milwaukee, WI) using an 8-channel phased-array
head coil. Diagnostic MR imaging at presentation included axial
T2-weighted (T2W; TR/TE = 6000/90 ms, 24 × 24 cm ﬁeld of view
(FoV), 384 × 384 Propeller acquisition, 1.5 averages, 28 × 5 mm slices,
1 mm slice gap), axial ﬂuid-attenuated inversion recovery (FLAIR;
TR/TE/TI = 9000/153/2200 ms, 24 × 24 cm FoV, 384 × 224 acquisition
matrix, 28 × 5 mm slices, 1 mm slice gap), gradient echo (GRE;
TR/TE=800/15ms, 20°ﬂip angle, 24× 18 cmFoV, 384× 168 acquisition
matrix, 2 averages, 28× 5mmslices, 1mmslice gap) and sagittal 3D T1-
weighted imaging (T1W; inversion recovery-prepared spoiled gradient
echo TR/TE/TI = 7.3/2.9/500 ms, 8° ﬂip angle, 330 × 214.5 cm FoV,
256 × 146 acquisitionmatrix, 100 × 1.8mm slices) and diffusion tensor
MRI (single-shot echo-planar imagingwith 30 diffusion directions (b=1000 s/mm) and 2 × b0 acquisitions, TR/TE = 7700/82 ms, 24 × 24 cm
FoV, 128 × 128 acquisition matrix, 28 × 5 mm slices, 1 mm slice gap).
DCE-MRI was performed at approximately 1 month after ﬁrst
presentation and consisted of a 3D T1W spoiled gradient echo sequence
with TR/TE= 8.24/3.1ms, 24× 24 cmFOV, 256× 192 acquisitionmatrix
and 42 × 4mm slices. Two pre-contrast acquisitionswere carried out at
ﬂip angles of 2° and 12° to enable the calculation of pre-contrast longi-
tudinal relaxation times (T10). An intravenous bolus injection of 0.1
mmol/kg of gadoterate meglumine (Gd-DOTA, Dotarem, Guerbet,
France) was administered simultaneously with the start of 20 acquisi-
tions with 12° ﬂip angle and a temporal resolution of 73 s, leading to a
DCE-MRI duration of approximately 24 minutes.Image processing
All image analysis was performed blind to clinical and permeability
data. All structural and DCE-MRI images were aligned to the 12° pre-
contrast image using rigid-body registration (FSL-FLIRT (Jenkinson
and Smith, 2001)) in order to correct for bulk patient movement. We
deﬁned all small vessel features according to agreed STRIVE standards
(Wardlaw et al., 2013b). We used a multispectral MRI data fusion and
minimum variance quantisation technique (Valdés Hernández et al.,
2010) for the segmentation of white matter hyperintensities (WMH)
and normal-appearing white matter (NAWM). Please note that we use
the term “WMH” to include hyperintensities in the white and subcorti-
cal grey matter. The resulting masks were manually reﬁned and, sepa-
rately, old stroke lesions and the index (i.e., which had led to patient
entry to the study) stroke lesion boundaries were semi-automatically
outlined on FLAIR images using the “Region of Interest” tool of Analyze
11.0TM (AnalyzeDirect, KS). Index/recent stroke lesions (RSL) were de-
ﬁned as the hyperintense regions identiﬁed on the diffusion weighted
image including any corresponding signal changes on FLAIR, T2W and
T1W images, associated with swelling or lack of ex vacuo effect, that
followed a vascular territory. Stroke lesion masks were checked for ac-
curacy by a neuroradiologist; all other tissue masks were checked visu-
ally for accuracy and manually edited as necessary. Subcortical/deep
grey matter (DGM) masks were generated automatically by a software
pipeline that used FSL-SUSAN (Smith and Brady, 1997) for noise reduc-
tion, an age-relevant brain template (Farrell et al., 2009), FSL-FLIRT for
aligning the template to each image data set and FSL-FIRST
(Patenaude et al., 2011) for extracting the subcortical structures, follow-
ed by manual boundary correction. To minimise any residual contami-
nation of the DGM, the mask was eroded by one voxel. An example of
a FLAIR image and segmentation masks is shown in Fig. 1.
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For each post-contrast time point i, we calculated the median signal
intensity over all voxels for each tissue type (Si). The signal enhance-
ment Ei (representing the fractional signal increase above baseline)
was then calculated as Ei=(Si− S0) / S0, where S0 is the signal intensity
of the 12° pre-contrast acquisition. T10 was calculated based on the var-
iable ﬂip angle method by Brookes et al. (Brookes et al., 1999) using
1
T10
¼ 1
TR
ln
SR sinαb cosαa− sinαa cosαb
SR sinαb− sinαa
 
; ð1Þ
where SR = Sa/Sb, with Sa and Sb representing the signal intensities of
the two pre-contrast acquisitions with ﬂip angles αa = 2° and αb =
12°. The contrast agent concentration Ciwas then estimated by numer-
ical solution of the following equation (Armitage et al., 2005):
Ei ¼ exp −r2CiTEð Þ
 1− exp −P−Qð Þ−cosαb exp Pð Þ− exp −2P−Qð Þð Þ
1− exp Pð Þ−cosαb exp P−Qð Þ− exp −2P−Qð Þð Þ
 
−1; ð2Þ
where P=TR/T10,Q=r1CiTR, longitudinal and transverse contrast agent
relaxivities r1 and r2 with r1/r2 = 4.2/6.7 s−1mM−1 (Rohrer et al.,
2005).
We obtained a vascular input function (VIF) from a voxel located on
the superior sagittal sinus (SS) since partial volume effects and inﬂow
artefact were reduced at that location compared with obtaining the
AIF from a feeding artery (Lavini and Verhoeff, 2010); the delay
between arterial and venous responses is expected to be very small com-
pared with the temporal resolution (Sourbron et al., 2009; Sourbron and
Buckley, 2012). Two observers, independently and blind to each other's
results, manually selected a single voxel for VIF extraction, using a slice
proximal to the basal ganglia structures and the lateral ventricles. This
voxel was chosen to provide a high peak signal enhancement and
smooth variation during the DCE-MRI time course. Where the observers
selected different voxels, the voxel with the highest peak enhancement
was chosen unless the signal curve was signiﬁcantly noisier (a noise
estimate was calculated as the sum of squared differences between the
signal curve and a ﬁtted bi-exponential curve). The calculated whole-
blood concentration Cb(t)measured in the SS was converted to plasma
concentration using the formula Cp(t) = Cb(t) / (1 − Hct), with the
most recent available haematocrit measurement in the patient's clinical
record (where no haematocrit measurement was available (n= 3) we
assumed Hct = 0.45).
Tracer kinetic modelling
Tracer kinetic modelling aims to provide a link between the tissue
signal enhancement and the physiological parameters, including the
fractional plasma volume vp, the fractional interstitial volume ve and
the permeability-surface area product PS. We ﬁtted the following
three models to the tissue concentration curves: (i) the modiﬁed ToftsFig. 2. Set of nested tracer kinetic models. Target parameters of DCE-MRI modelling are the fra
permeability-surface area product PS. The four models are related by a series of simplifying assmodel (Tofts et al., 1999), (ii) the Patlak model (Patlak et al., 1983)
and (iii) the steady-state model (Sourbron and Buckley, 2013). A
schematic overview of these models and their relationship with the
more general two-compartment-exchange model (2CXM) (Sourbron
and Buckley, 2013) is shown in Fig. 2.
Themodiﬁed Tofts model describes a highly perfused (Fp=∞) two-
compartment tissue, considering bidirectional transport between the
blood plasma and the extracellular extravascular space (EES). The
concentration of contrast agent in the tissue is given by
Ct tð Þ ¼ vpCp tð Þ þ KTrans∫t0Cp τð Þ exp −
KTrans t−τð Þ
ve
" #
dτ; ð3Þ
where the volume transfer constant KTrans represents the rate at which
contrast agent is delivered to the EES per volume of tissue and contrast
agent concentration of the VIF (PS denotes the same transfer constant
with respect to capillary plasma concentration); in general, the mea-
sured KTrans depends on both the plasma ﬂow Fp and the permeability-
surface area product PS; however, if the assumptions of the model are
met (i.e., ﬂow is high enough and the rate of contrast extravasation is
low enough to ensure equal concentration in the arteries and capillary
bed) and the measurement process is accurate, then KTrans ≈ PS is a
good approximation (Sourbron and Buckley, 2013). In the work that
follows, we use the symbol KTrans to indicate experimental or simulated
measurements and PS to indicate the permeability-surface area product
used to generate simulated data.
The Patlak model can be seen as a special case of the modiﬁed Tofts
model, which ignores backﬂux from the EES into the blood plasma
compartment. Consequently, it only allows for the estimation of the
two parameters KTrans and vp:
CtðtÞ ¼ vpCp tð Þ þ KTrans∫t0Cp τð Þ dτ: ð4Þ
If it is further assumed that there is no transfer of contrast to the EES,
the one-parameter steady-state model (Sourbron and Buckley, 2013) is
obtained:
CtðtÞ ¼ vpCp tð Þ: ð5Þ
Model ﬁtting was performed using in-house software programmed
in MATLAB (MathWorks, Natick, MA, USA) by non-linear minimisation
of the sum of squared residuals. All parameters were restricted to posi-
tive values, and vp + ve was constrained to be less than or equal to 1;
ﬁtting was repeated 25 times with different initial values to reduce
the probability of selecting local minima (Ahearn et al., 2005). The
ﬁrst three post-contrast time points of all contrast agent concentration
curves were omitted from sum of squares calculation since the rapid
concentration changes during and immediately after the ﬁrst pass are
not adequately resolved by the acquisition protocol and are not accu-
rately modelled by any of the three nested models (Larsson et al.,ctional plasma volume vp, the fractional interstitial volume ve, the plasma ﬂow Fp and the
umptions.
449A.K. Heye et al. / NeuroImage 125 (2016) 446–4552009), resulting in biased parameter estimates that depend on Fp; this
was conﬁrmed by computer simulations.
Model comparison
The competing models were ranked according to the Akaike
information criterion (AIC) (Akaike, 1974), which has been applied in
DCE-MRI by several groups (Brix et al., 2009; Ingrisch et al., 2010).
The AIC accounts for the trade-off between goodness-of-ﬁt and model
complexity, by combining the sum of squared errors SSm with the
number of free parameters Km associated with the model m:
AICm ¼ N ln SSmN
 
þ 2 Km þ 1ð Þ; ð6Þ
where N denotes the number of data points. For small samples,
i.e., N/Km b 40 as in our case, the AIC should be extended with a
second-order bias correction term (Burnham and Anderson, 2004),
giving the small-sample version
AICcm ¼ AICm þ 2Km Km þ 1ð ÞN−Km−1 : ð7Þ
The Akaike weight AWm describes the probability that the modelm
is best amongst a set of M models, following the equation (Luypaert
et al., 2012)
AWm ¼ exp −Δm=2ð ÞXM
i¼1 exp −Δi=2ð Þ
with Δm ¼ AICcm−min AICc1;… ; AICcMð Þ:
ð8Þ
For a statistical comparison between tracer kinetic parameters,
Wilcoxon's signed rank test (since the data were in general not normally
distributed) was used.
Healthy volunteers
To assess signal changes unrelated to the contrast agent, we recruited
15 healthy volunteers that underwent the sameDCE-MRI protocol as ap-
plied in the clinical cohort but without administration of contrast agent.
This study was approved by ACCORD Healthy Volunteer Research Ethics
Committee (REC 14/HV/0001), and all volunteers gavewritten informed
consent. We manually placed regions of interest (ROIs) in NAWM and
DGM and calculated median signal intensity and enhancement curves
for each ROI as described previously. Signal drift was calculated as the
overall change in signal intensity per minute and is given as percentage
of the time-averaged signal.
In addition to the dynamic sequence, we accurately measured T1
using the inversion recovery method (Larsson et al., 1988) (IR) in
n= 7 volunteers. For this purpose, we acquired 2D inversion recovery
spin echo echo-planar imaging with multiple inversion times (IR-SE-
EPI; TR/TE= 10000/25.4ms, 24 × 24 cm FOV, 256 × 192 acquisitionma-
trix, 1 × 4 mm slice, TI = [100, 340, 580, 820, 1060, 1300, 2000, 3000]
ms). T1 was calculated by ﬁtting the following equation to the median
ROI signal intensities (SI):
SI ¼ Aþ B exp − T I
T1
 
 ð9Þ
T1 was measured immediately before and after the non-contrast
DCE-MRI acquisition, yielding the two measurements T1,pre (before
DCE-MRI) and T1,post (after DCE-MRI). All values are given as mean
and standard deviation.Simulations
Numerical simulationswere performed to systematically investigate
model validity. First, we generated a high-resolution (Δt = 0.1 s) VIF
using the function introduced by Parker et al., (2006), which consists
of two Gaussians plus an exponential term modulated by a sigmoid
function. In order to generate a simulated VIF with realistic ﬁrst-pass
behaviour that also matched our data at longer times post-injection,
we introduced an additional exponential term resulting in the following
function:
Cp tð Þ ¼ 11−Hct
X
n ¼ 12 An
σn
ﬃﬃﬃﬃﬃﬃ
2π
p exp − t−Tnð Þ
2
2σ2n
 !
þ
X
n ¼ 12αn exp −βntð Þ
1þ exp −s t−τð Þð Þ
 !
:
ð10Þ
For the Gaussian functions and sigmoid modulation, which describe
the ﬁrst and second pass of the VIF, we used the parameters given by
Parker et al. (An, σn, Tn, s, τ). The parameters αn and βn were obtained
by ﬁtting Eq. (10) to the population-average VIF from our patient data
(Supplementary Fig. 1). Simulated tissue concentration curves were
generated by convolving this VIF with the impulse response function
of the 2CXM, which has four free parameters: Fp, PS, vp and ve
(Sourbron and Buckley, 2013). PS and vp values were chosen to repre-
sent the range of values obtained in normal-appearing tissue, WMH
and stroke lesions; ve was chosen to be 0.2 (Syková and Nicholson,
2008) and Fp values between 10 and 50 ml/100 g/min were selected
to represent typical values for NAWM, WMH and DGM (Brickman
et al., 2009). Randomnoisewas added to the curves to give a concentra-
tion contrast-to-noise ratio (CNR) similar to that observed in NAWM
and DGM in our clinical cohort; the CNR was deﬁned as the peak
contrast agent concentration divided by a noise estimate, which was
calculated as the standard deviation of the difference between themea-
sured concentration curve and the Patlakmodel ﬁt (CNR=max[Ct(t)] /
std[Ct(t)− CPatlak(t)]). Simulations were repeated, adding a signal drift
to both the tissue curve and the VIF. The added drift was of similar
magnitude to that found in the healthy volunteer cohort (values given
in the results section). We then down-sampled the VIF and tissue con-
centration curves to the experimental temporal resolution (Δt= 73 s),
and these were ﬁtted to the Patlak model as described above. We
also calculated the semi-quantitative parameters AUCnorm (deﬁned as
the area under the tissue enhancement curve divided by the area
under the vascular enhancement curve) and the late slope of the
enhancement curve (obtained by linear regression of the tissue signal
enhancement data). As for the clinical data, the ﬁrst three post-
contrast data points were neglected for calculating the sum of squared
residuals during model ﬁtting and for calculation of semi-quantitative
parameters. The simulations were repeated 1000 times for every set
of parameters to quantify the inﬂuence of noise.
Results
Patients
DCE-MRI was performed on average 38 days after ﬁrst presentation
and data suitable for analysis were obtained in 201 patients with mean
age of 66.0 ± 11.5 years. Fig. 3 shows the cohort-averaged signal
enhancement curves in NAWM, DGM, WMH, RSL and SS. All tissues
showa signal enhancement of approximately 2%–8%,with abnormal tis-
sues (WMHand RSL) showing a steeper increase in signal enhancement
over time compared with normal-appearing tissues (WM and DGM).
An example of tracer kinetic model ﬁtting for a single patient is
shown in Fig. 4A; the Patlak and modiﬁed Tofts models provide good
ﬁts to the measured signal but the steady-state model is not sufﬁcient
to describe the data. This observation is conﬁrmed by analysis of the
Akaike weights (Fig. 4B), which shows that the Patlak model best
Fig. 3. Cohort average signal enhancement curves. Post-contrast signal enhancement
versus time obtained from the median signal intensity in each tissue type (NAWM:
normal-appearing white matter, WMH: white matter hyperintensities, DGM: deep
grey matter, RSL: recent stroke lesion, SS: sagittal sinus) and averaged over all patients
(n= 201). Y-axis scales for the tissue and sagittal sinus enhancement curves are shown
on the left and right, respectively.
Table 1
Fitted Patlak parameters. Values are shown as mean ± standard error in normal-
appearing white matter (NAWM), white matter hyperintensities (WMH), deep grey
matter (DGM) and recent stroke lesions (RSL). All differences between tissue types were
signiﬁcant (p b 0.001) except for KTrans in WMH and DGM and vp in WMH and RSL.
KTrans (×10−4 min−1) vp (×10−2)
NAWM 2.96 ± 0.12 0.58 ± 0.02
WMH 3.96 ± 0.13 0.80 ± 0.04
DGM 3.91 ± 0.12 1.21 ± 0.03
RSL 5.77 ± 0.41 0.80 ± 0.05
450 A.K. Heye et al. / NeuroImage 125 (2016) 446–455represents the data inmost subjects for all tissue types, andwas selected
as the optimummodel in 74%–78% of patients for the four tissues mea-
sured. The resulting Patlak parameters are listed in Table 1. A comparison
between tissue types is shown in Fig. 5; all differences between tissue
types were signiﬁcant (p b 0.001) except for KTrans in WMH and DGM
and vp in WMH and RSL. In particular, KTrans and vp are signiﬁcantly
higher in WMH compared to NAWM; KTrans is signiﬁcantly higher in
RSL compared to all other tissues.Healthy volunteers
DCE-MRI data without contrast administration was obtained in 15
healthy volunteerswithmean age 31.4±7.4 years. Fig. 6A shows the cor-
responding average signal enhancement curves in NAWM and DGM. The
data show an approximately linear drift in signal intensity of 0.10 ±
0.06%/min in DGM and 0.06 ± 0.03%/min in NAWM. To investigate
whether part of thedrift canbe explainedby subtle physiological changes,
we accuratelymeasured T1 before and after the DCE-MRI sequence in 8 of
the volunteers. T1 values were in line with previous literature (Vymazal
et al., 1999) with T1,pre/T1,post =903 ± 66 ms / 892 ± 53 ms in DGM
and T1,pre/T1,post = 680 ± 40 ms / 674 ± 41 ms in NAWM (see Fig. 6B);
the small decrease in T1 over the period of the DCE-MRI acquisition
was not statistically signiﬁcant (ΔT1 = −11 ± 20 ms in DGM and
ΔT1=−7 ± 14 ms in NAWM).Fig. 4. Comparison of model ﬁts to the patient data. (A) Example concentration–time curve for
not ﬁt the data well; while both the Patlak and modiﬁed Tofts (mTofts) models typically ﬁt the
Tofts model in most cases due to the lower number of free parameters. (B) Comparison o
hyperintensities (WMH), deep grey matter (DGM) and recent stroke lesions (RSL). In most paSimulations
The results of simulations performed to determine the validity of the
Patlakmodel are shown in Fig. 7. These compare ﬁtted parameters with
the “true” parameters used to generate synthetic signal-time curves
using the 2CXM model. All simulations are based on a CNR of 8 and a
T1 of 969 ms, corresponding to typical NAWM values observed in our
patient cohort. In the absence of drift (Fig. 6A), KTrans≈ PS and vp is ac-
curately estimatedwhen PS is low, despite very low temporal resolution
and the simplifying assumptions of the Patlak model. At higher PS
values, KTrans underestimates PS, and vp is slightly overestimated as a
result of back-diffusion, which is neglected in the Patlak model. The
model is robust to differences in blood ﬂow, with low ﬂow resulting in
a slightly greater underestimation of PS. To investigate the effect of scan-
ner drift, we included a 0.08%/min signal drift (comparable to that mea-
sured in the healthy volunteer group) in the simulations. This leads to
systematic underestimation of vp and overestimation of leakage
(Fig. 6B), but KTrans and vp remain approximately linear functions of
the speciﬁed values, largely independent of plasma ﬂow and of one an-
other. The magnitude of the systematic error introduced by signal drift
is T1 dependent, with an estimated range across the tissues of approxi-
mately 2.2–3.2 × 10−4min−1 for KTrans and−2.4 to−1.6 × 10−3 for vp.
For comparison, Fig. 8 shows the relationship between PS and vp, and
the semi-quantitative parameters AUCnorm and the late slope of the
signal enhancement curve. AUCnorm correlates strongly with vp but is
also inﬂuenced by PS. Similarly, the enhancement slope correlates
with PS but is not independent of vp.
Discussion
Analysis of patient DCE-MRI data using the Akaike information crite-
rion revealed the Patlak model to be the most appropriate of the three
models for quantiﬁcation of subtle BBB disruption, in line with our
hypothesis. The steady-state model does not adequately ﬁt the data;normal-appearing white matter in a single patient. In general, the steady-state model does
data similarly well, the Patlak model has a higher Akaike weight (AW) than the modiﬁed
f AW for the three models in normal-appearing white matter (NAWM), white matter
tients, the Patlak model had the highest AW for all tissue types (legend as in A).
Fig. 5. Comparison of ﬁtted Patlak parameters between tissue types. Box plots showing the distribution of KTrans (left) and vp (right) in normal-appearing white matter (NAWM), white
matter hyperintensities (WMH), deep greymatter (DGM) and recent stroke lesions (RSL). Bracketswith n.s. indicate non-signiﬁcant differenceswith p N 0.5; all other differences between
tissue types are signiﬁcant with p b 0.001 (brackets omitted for clarity).
451A.K. Heye et al. / NeuroImage 125 (2016) 446–455while both the Patlak and modiﬁed Tofts models ﬁt the data similarly
well, the simpler Patlak model does so using fewer free parameters
and is therefore selected. The additional complexity of the modiﬁed
Tofts model results in over-ﬁtting in the low-permeability regime,
consistent with a previous report regarding the behaviour of Tofts
parameters in a smaller study of healthy volunteers and MS patients
(Cramer and Larsson, 2014). Application of the Patlak model in situa-
tions of subtle BBB leakagewas further supported by the numerical sim-
ulations, conﬁrming that appropriate estimates of PS (≈KTrans), and vp
can be obtained independent of cerebral blood ﬂow (CBF) and despite
the use of a temporal resolution much lower than is typically employed
in DCE-MRI (Heye et al., 2014); this was consistent with simulations
performed by Larsson et al. for a shorter, high temporal resolution
acquisition (Larsson et al., 2009). A consequence of this ﬁnding is that
DCE-MRI protocols for investigating diffuse subtle BBB pathology may
beneﬁt from prioritising, as here, spatial resolution, whole-brain cover-
age and contrast-to-noise ratio over sampling rate to allow for analysis
of subtle leakage across all brain structures. In contrast to the ﬁtted
tracer kinetic parameters, we found semi-quantitative parameters to
reﬂect a combination of underlying tissue properties.
In our cohort ofmild stroke patients,KTranswas greater inWMH than
in NAWM. This is consistent with some pathology studies (e.g.,
Tomimoto et al., 1996; Wharton et al., 2015; Young et al., 2008) and
other DCE-MRI studies that reported increased BBB disruption in areas
of WMH compared to NAWM (Hanyu et al., 2002; Taheri et al., 2011a;
Topakian et al., 2010). In contrast, a recent study by Huisa et al. found
increased BBB disruption in NAWM surrounding the WMH rather
than in the WMH themselves (Huisa et al., 2015), while others failedFig. 6. Contrast-free measurements in healthy volunteers. (A) Average signal enhancement cu
showing a drift in signal intensity; error bars indicate the mean ± standard error. (B) T1 meas
method (n= 7); error bars indicate the mean ± 1.96 standard deviations.to detect any BBB leakage in or around WMH (Wahlund and Bronge,
2000). The exact role of BBB breakdown in SVD pathology remains to
be deﬁned. KTrans was greater still in the recent stroke lesion, compara-
ble to ﬁndings of Thornhill et al. in acute-phase stroke lesions (Thornhill
et al., 2010) and known tissue changes frommany pathology examina-
tions. KTrans was greater in GM than in NAWM, whichmay partly reﬂect
the higher vessel density and vascular surface area of GM (Schlageter
et al., 1999), consistentwith the highermeasured blood plasma volume.
WMH, which are often regarded as “ischaemic” lesions and might
therefore be expected to have reduced plasma volume, had greater vp
than NAWM. This ﬁnding is only partly explained by the T1 difference
between the tissues, which results in a predicted greater underestima-
tion of vp in NAWM due to scanner drift. Assumptions such as tissue-
independent relaxivity and water exchange rates may also inﬂuence
the values. Another possible explanation is that a few WMH are found
in tissue that was originally subcortical grey matter, especially in the
head of the caudate nucleus, where baseline blood volume is likely to
be higher. Very few studies have measured cerebral blood volume
(CBV) and CBF in WMH themselves, as opposed to general CBV and
CBF in patients with WMH. While some studies using DSC-MRI have
reported reduced CBV in WMH, e.g., Sachdev et al. (2004), Marstrand
et al. (2002) found reduced CBF but similar CBV in WMH compared
with NAWM. Although DCE-MRI is a more quantitative marker of
microvascular properties than DSC-MRI, previous studies applying
DCE-MRI in SVD have not reported vp values for WMH to the best
of our knowledge. We suggest therefore that future studies should
assess CBF and CBV in WMH as well as normal tissues so as to resolve
this issue.rves (n= 15) in normal-appearing white matter (NAWM) and deep grey matter (DGM),
urements obtained before and after the DCE-MRI sequence using the inversion recovery
Fig. 7. Simulated accuracy of Patlak parameters. (A) Relationship of permeability-surface area product PS (top row) and blood plasma volume vp (bottom row) values, with corresponding
ﬁtted Patlak parameters. Results are shown for two different blood plasma ﬂow (Fp), PS and vp values. For all simulations, the interstitial volume was set to 0.2. Error bars indicate the
mean ± 1.96 standard deviations; the grey line represents the identity line. (B) As above but including a 0.08%/min signal drift.
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change of approximately 0.08%/min. This level of instability is unlikely
to be problematic in typical DCE-MRI applications with larger, more
rapid signal enhancements over shorter acquisition times. However,
our simulations show that the drift is predicted to cause a substantial
upward shift of KTrans measurements in the low-permeability regime,which would account for some of the apparent leakage seen in
normal-appearing white matter and other tissues. As a result, attempts
to quantify low levels of permeability should be interpreted with
caution, unless information regarding scanner drift and its likely effect
on the values are available. This ﬁnding is consistent with recently
reported simulation results (Barnes et al., 2015) andmay partly account
Fig. 8. Relationship between simulated semi-quantitative parameters and tissue properties. (A) Relationship between the signal enhancement slope and the permeability-surface
area product PS for different blood plasma volumes vp. (B) Relationship between normalised area under the signal enhancement curve and vp for different PS values. A signal drift of
0.08%/min was added to the synthetic data; results are shown for blood plasma ﬂow Fp = 10 ml/100 g/min and interstitial volume ve = 0.2.
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normal-appearing brain tissue (Cramer et al., 2014; Larsson et al.,
2009; Montagne et al., 2015; Sourbron et al., 2009; Taheri et al.,
2011a, 2011b; Thornhill et al., 2010), which span three orders ofmagni-
tude and include negative values (Sourbron et al., 2009). Signal drift
measurements are rarely reported in the DCE-MRI literature, an excep-
tion being Cramer et al. who reported a drift at 3 T (1%–3% over 15 mi-
nutes) comparable to our measurements at 1.5 T (Cramer and Larsson,
2014). The drift behaviour of our scanner was also within the range of
values obtained in a multi-centre survey of fMRI quality assurance
parameters, which concluded that “stable scanners generally average
around 1.0% [signal drift over 6.7 minutes] or less” (Friedman and
Glover, 2006). The inﬂuence of signal drift in fMRI is much less severe
than here since it typically has a lower frequency than the task-related
signal change, is suppressed using a high-pass ﬁlter and the scans are
quicker; in DCE-MRI, it is harder to distinguish between drift and
contrast enhancement as both occur on similar timescales. It is worth
noting that DCE-MRI methods consisting of repeated T1 measurements
(e.g., Taheri et al., 2011b) should largely self-compensate for signal
drifts of instrumental origin and, depending on the pulse sequence
used, changes in the radiofrequency ﬁeld strength. However, the causes
of signal drift are not well-understood and may also be inﬂuenced by
subtle biological changes (Lowe and Russell, 1999), consistent with
our (non-signiﬁcant) observation of T1 change and by a previous report
of tissue-dependent drift on the same scanner as in the present work
(Armitage et al., 2011). The effect should also be mitigated by
optimising the protocol for sensitivity to changes in contrast agent
concentration.
Despite the potentially confounding inﬂuence of drift, our simulations
indicate that KTrans and vp estimates remain approximately linear inde-
pendent functions of the permeability-surface area product and plasma
volume, respectively. They provide a valuable if relative indication of
blood–brain barrier integrity and blood plasma volume for applications
in well-designed studies with appropriate control groups and statistical
correction for confounds; such quantities remain easier to interpret than
semi-quantitative measurements (Budde et al., 2012).
This and other DCE-MRI studies are limited by additional sources of
error, which have been described elsewhere. For example, the variable
ﬂip angle method (also known as “DESPOT1”) used here and in many
other studies (Homer and Beevers, 1985) has the advantage of yielding
T1 maps with whole-brain coverage and adequate SNR within an ac-
ceptable acquisition time. However, it is sensitive to ﬂip angle variations
across the brain, i.e., deviations of the actual from the operator deﬁned
ﬂip angles caused by B1 ﬁeld inhomogeneities and the slab excitation
proﬁle of the radiofrequency pulse, resulting in errors in T10 and other
parameters (Armitage et al., 2011; Schabel and Parker, 2010). At 1.5 T
and using a radiofrequency transmit volume coil, such ﬂip anglevariations should be limited and reasonably consistent within the co-
hort. In future studies, especially on scanners with higher ﬁeld strength,
it would be prudent to either employ methods that estimate and/or
correct for ﬂip angle errors, such as DESPOT1-HIFI (Deoni, 2007).
Look–Locker-based methods such as TAPIR (Shah et al., 2001) also
provide an alternative approach for T10 measurement, permitting faster
sampling of the magnetization recovery curve than the conventional
inversion recovery method. The sensitivity of these methods to ﬂip
angle variations is reduced since the ﬂip angle can be modelled as an
unknown parameter during ﬁtting of the inversion recovery curve. It
should also be recognised that all tracer kinetic models necessarily
make assumptions regarding tissue structure and the transport of
blood plasma and contrast agent. For example, as the low temporal
resolution of our acquisition protocol does not permit estimation of
bloodﬂow,we selected threemodels that assume the tissue to be highly
perfused (i.e., Fp = ∞). Although this is not the case in real tissues, it
remains a good approximation when the blood ﬂow is sufﬁcient to
equalise the arterial and capillary concentrations (requiring PS bbFp)
(Sourbron and Buckley, 2011), with our simulations conﬁrming the
validity of this approximation; the choice of models should also be
seen in relation to temporal resolution, which in this case is much
longer than the transit time of the tissue blood compartment. It should
also be emphasised that while PS (or KTrans) is commonly used as a
marker of “permeability,” it is equally inﬂuenced by the capillary surface
area,whichwill depend on the anatomy and pathology ofmicro vessels.
Future studies should try to determine vessel density and size so as to
include realistic estimates of capillary endothelial surface area in the
permeability calculations. Furthermore, a disadvantage of low temporal
resolution acquisition is that cerebral blood ﬂow cannot be determined
in addition to vp and PS; where knowledge of CBF is required and tem-
poral resolution is adequate, the uptake model may be substituted for
the Patlak model in low-permeability tissue (Ingrisch et al., 2012;
Sourbron et al., 2009). Finally, the DCE-MRI data in this study has been
analysed at the level of ROIs rather than voxels. This approach was
selected due to the low contrast-to-noise ratio in single voxels and
due to the inﬂuence of artefacts (e.g., Gibbs ringing and motion),
which, while typically at the level of only a few percent, have a similar
magnitude to the small contrast-induced signal changes and therefore
have a disproportionate inﬂuence on voxel-wise pharmacokinetic
parameters (Supplementary Fig. 2). Averaging over an ROI reduces the
inﬂuence of noise and artefact, enabling more robust measurement of
background BBB status, especially in normal-appearing tissue where
signal changes are small. However, a limitation of this approach is that
it does not allow the detection of local variation in BBB function.
In conclusion, the Patlak model is a simple and appropriate method
for measuring low-level BBB leakage, and our results, based on a large
sample of mild stroke patients, justify its emerging popularity in the
454 A.K. Heye et al. / NeuroImage 125 (2016) 446–455study of disorders involving subtle BBB disruption and of healthy-
appearing tissue (Cramer et al., 2014; Montagne et al., 2015; Taheri
et al., 2011a). The model is reasonably robust to the assumptions of
high blood ﬂow and negligible back-diffusion, but the resulting tracer
kinetic parameters are inﬂuenced by signal drift particularly at low-
permeability states. It is therefore important to optimise study MRI
protocols for measurement of low-level permeability and to assess the
magnitude and consistency of drift in future studies by performing
non-contrast experiments in volunteers as done here or in a subset of
patients (Armitage et al., 2011; Cramer and Larsson, 2014) and simula-
tions to predict the likely effect on study ﬁndings. These considerations
are particularly critical for multi-centre studies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neuroimage.2015.10.018.
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